Oral treprostinil in transition or as add-on therapy in pediatric pulmonary arterial hypertension

Oral treprostinil in transition or as add-on therapy in pediatric pulmonary arterial hypertension

Treprostinil, a prostacyclin analogue, is approved for the treatment of pulmonary arterial hypertension (PAH) in adults. Transition from parenteral to oral treprostinil has been successfully accomplished in adults with PAH but not in children. In this multicenter study, pediatric patients treated wi...

Full description

Bibliographic Details
Main Authors: D. Dunbar Ivy, Jeffrey A. Feinstein, Delphine Yung, Mary P. Mullen, Edward C. Kirkpatrick, Russel Hirsch, Eric D. Austin, Jeffrey Fineman, Uyen Truong, Derek Solum, C.Q. Deng, Rachel K. Hopper
Format: Article
Language:English
Published: SAGE Publishing 2019-07-01
Series:Pulmonary Circulation
Online Access:https://doi.org/10.1177/2045894019856471

Internet

https://doi.org/10.1177/2045894019856471

Similar Items